tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Hershenhorn, 3 are a HOLD (100%).
Analyst Matthew Hershenhorn, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 100% that have a potential upside of 9.69% achieved within 194 days.
Matthew Hershenhorn’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 05-Aug-2026.
Analyst best performing recommendations are on ACAD (ACADIA PHARMACEUTICALS).
The best stock recommendation documented was for ACAD (ACADIA PHARMACEUTICALS) at 8/5/2026. The price target of $25 was fulfilled within 50 days with a profit of $3.8 (13.19%) receiving and performance score of 2.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jun-2022
$38
$16.53 (76.99%)
$36
6 days ago
(06-Nov-2026)
13/23 (56.52%)
$16.53 (76.99%)
197
Buy Since 23-Jun-2025
$38
$16.53 (76.99%)
$36
6 days ago
(06-Nov-2026)
1/12 (8.33%)
$16.53 (76.99%)
173
Buy Since 28-Feb-2024
$35
$13.53 (63.02%)
$35
24 days ago
(19-Oct-2026)
9/16 (56.25%)
$15.2 (76.77%)
393
Buy Since 15-Dec-2025
$33
$11.53 (53.70%)
$37
1 months 18 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$12.53 (58.36%)
$36
1 months 18 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Which stock is Matthew Hershenhorn most bullish on?
What Year was the first public recommendation made by Matthew Hershenhorn?
